215 related articles for article (PubMed ID: 7531356)
21. Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist.
Hildebrand P; Lehmann FS; Ketterer S; Christ AD; Stingelin T; Beltinger J; Gibbons AH; Coy DH; Calam J; Larsen F; Beglinger C
Gut; 2001 Jul; 49(1):23-8. PubMed ID: 11413106
[TBL] [Abstract][Full Text] [Related]
22. Different types of bombesin receptors on neurons in the dorsal raphe nucleus and the rostral hypothalamus in rat brain slices in vitro.
Pinnock RD; Reynolds T; Woodruff GN
Brain Res; 1994 Aug; 653(1-2):119-24. PubMed ID: 7982044
[TBL] [Abstract][Full Text] [Related]
23. [Leu13-psi(CH2NH)Leu14]bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells.
Woll PJ; Coy DH; Rozengurt E
Biochem Biophys Res Commun; 1988 Aug; 155(1):359-65. PubMed ID: 2843183
[TBL] [Abstract][Full Text] [Related]
24. Role of endogenous bombesin-peptides during vagal stimulation of gastric acid secretion in the rat.
Weigert N; Li YY; Lippl F; Coy DH; Classen M; Schusdziarra V
Neuropeptides; 1996 Dec; 30(6):521-7. PubMed ID: 9004248
[TBL] [Abstract][Full Text] [Related]
25. Blockade of GRP receptors inhibits gastric emptying and gallbladder contraction but accelerates small intestinal transit.
Degen LP; Peng F; Collet A; Rossi L; Ketterer S; Serrano Y; Larsen F; Beglinger C; Hildebrand P
Gastroenterology; 2001 Feb; 120(2):361-8. PubMed ID: 11159876
[TBL] [Abstract][Full Text] [Related]
26. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes.
Mantey S; Frucht H; Coy DH; Jensen RT
Mol Pharmacol; 1993 May; 43(5):762-74. PubMed ID: 7684815
[TBL] [Abstract][Full Text] [Related]
27. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
[TBL] [Abstract][Full Text] [Related]
28. Comparison of prolonged in vivo inhibitory activity of several potent bombesin (BN) antagonists on BN-stimulated amylase secretion in the rat.
Alptekin N; Yagci RV; Ertan A; Jiang NY; Rice JC; Sbeiti M; Rossowski WJ; Coy DH
Peptides; 1991; 12(4):749-53. PubMed ID: 1724078
[TBL] [Abstract][Full Text] [Related]
29. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
[TBL] [Abstract][Full Text] [Related]
30. Hindbrain GRP receptor blockade antagonizes feeding suppression by peripherally administered GRP.
Ladenheim EE; Taylor JE; Coy DH; Moore KA; Moran TH
Am J Physiol; 1996 Jul; 271(1 Pt 2):R180-4. PubMed ID: 8760218
[TBL] [Abstract][Full Text] [Related]
31. Modulation of inositol lipid hydrolysis in human breast cancer cells by two classes of bombesin antagonist.
Patel KV; Schrey MP
J Mol Endocrinol; 1991 Feb; 6(1):71-8. PubMed ID: 1707628
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the bombesin receptor on mouse pancreatic acini by chemical cross-linking.
Huang SC; Yu DH; Wank SA; Gardner JD; Jensen RT
Peptides; 1990; 11(6):1143-50. PubMed ID: 1708135
[TBL] [Abstract][Full Text] [Related]
33. Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi.
Cai RZ; Radulovic S; Pinski J; Nagy A; Redding TW; Olsen DB; Schally AV
Peptides; 1992; 13(2):267-71. PubMed ID: 1409006
[TBL] [Abstract][Full Text] [Related]
34. Short chain bombesin pseudopeptides with potent bombesin receptor antagonist activity in rat and guinea pig pancreatic acinar cells.
Coy D; Wang LH; Jiang NY; Jensen R
Eur J Pharmacol; 1990 Nov; 190(1-2):31-8. PubMed ID: 1963850
[TBL] [Abstract][Full Text] [Related]
35. Effect of the gastrin-releasing peptide antagonist BIM 26226 and lanreotide on an acinar pancreatic carcinoma.
Damgé C; Hajri A
Eur J Pharmacol; 1998 Apr; 347(1):77-86. PubMed ID: 9650851
[TBL] [Abstract][Full Text] [Related]
36. Effect of the bombesin receptor blockers [Leu13, psi CH2NH-Leu14]bombesin and N-pivaloyl GRP(20-25) alkylamide (L 686,095-001C002) on basal and neuromedin C-stimulated PRL and GH release in pituitary cell aggregates.
Houben H; Denef C
Peptides; 1991; 12(2):371-4. PubMed ID: 1648716
[TBL] [Abstract][Full Text] [Related]
37. Effects of potent bombesin antagonist on exocrine pancreatic secretion in rats.
Varga G; Reidelberger RD; Liehr RM; Bussjaeger LJ; Coy DH; Solomon TE
Peptides; 1991; 12(3):493-7. PubMed ID: 1717952
[TBL] [Abstract][Full Text] [Related]
38. Bombesin receptor antagonists block the effects of exogenous bombesin but not of nutrients on food intake.
Flynn FW
Physiol Behav; 1997 Oct; 62(4):791-8. PubMed ID: 9284499
[TBL] [Abstract][Full Text] [Related]
39. Effects of neuromedin B and neuromedin C on exocrine and endocrine rat pancreas.
Otsuki M; Fujii M; Nakamura T; Tani S; Oka T; Yajima H; Baba S
Am J Physiol; 1987 Apr; 252(4 Pt 1):G491-8. PubMed ID: 2436486
[TBL] [Abstract][Full Text] [Related]
40. Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives.
Cai RZ; Reile H; Armatis P; Schally AV
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12664-8. PubMed ID: 7809097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
